20 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer
DEF 14A
4x9wk dwjr5kspb3l
26 Apr 22
Definitive proxy
4:05pm
10-K
1u64mwhn2c26
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
5e2qskyh8
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
50pvb 2uw6
2 Dec 21
Quarterly report
4:15pm
424B4
gunf2u7yr0lf
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
tfkl7uwpdcoph9
18 Oct 21
IPO registration (amended)
6:04am
S-1
4pje7
1 Oct 21
IPO registration
4:49pm
DRS/A
17g5ewv
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
duoficih6uae 1v2cfp
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next